z-logo
Premium
TNFα‐308G/A Genotype is Associated with Muscle Mass in Humans
Author(s) -
Liu Dongmei,
Metter E. Jeffrey,
Ferrucci Luigi,
Roth Stephen M.
Publication year - 2007
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.21.6.a1308-d
Subject(s) - genotype , tumor necrosis factor alpha , muscle mass , allele , medicine , endocrinology , necrosis , skeletal muscle , confounding , genotype frequency , biology , chemistry , polymorphism (computer science) , gene , genetics
PURPOSE: Tumor necrosis factor alpha (TNFa) has been implicated in the regulation of muscle protein metabolism. A promoter polymorphism in the TNFa gene (TNFa −308 G/A) has been associated with higher production of TNFa. In this study, the relationship between TNFa −308G/A genotype and muscle mass was investigated in adult individuals. METHODS: 1095 participants of Baltimore Longitudinal Study of Aging (BLSA) (age range: 19 to 97 yr, 529 females and 566 males) were genotyped for TNFa −308G/A. Skeletal muscle mass (measured by DXA) was compared among different genotype groups. Age, gender, race and height were accounted for as confounding factors. RESULTS: TNFa genotype was significantly associated with both total body lean mass (LM) (p<0.0001) and appendicular skeletal muscle mass (ASMM) (p=0.0021). The AA genotype group (n=28) had higher muscle mass than the GA and GG groups (n=306 and 760) (LM: 68.1±2.2 vs. 56.2±0.6 and 56.6±0.4kg, p<0.0001; ASMM: 29.4 ±1.3 vs. 24.1±0.4 and 24.3±0.3kg, p=0.0006). Due to limitation in sample sizes, further analysis in subgroups only showed significant associations between TNFa genotype and muscle mass in white males (LM: P<0.0001; ASMM: p=0.0016). CONCLUSIONS: TNFa −308G/A genotype was significantly associated with muscle mass, with AA homozygotes having higher muscle mass than G allele carriers in healthy individuals. Supported by intramural NIH‐NIA funds, AG21500 and AG22791.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here